logo

For the Inventor, By the Inventor

Cologne, Germany

Wolfgang Dompert

This inventor holds 15 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignees: Bayer Aktiengesellschaft, Troponwerke Gmbh & Co Kg, Troponwerke Gmbh & Co.. Active years: 1989-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wolfgang Dompert. Retrieved from https://idiyas.com/inventor/wolfgang-dompert

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 15

% Patents Active = 100.0

Average Co-Inventor Count = 6.3

ph-index = 7

Forward Citations = 151(Granted Patents)


Location History:

  • Roesrath-Forsbach, DE (1989 - 1994)
  • Cologne, DE (1994 - 1999)
  • Koln, DE (2000)

Company Filing History:

goldMedal10 out of 12,270 
 
Bayer Aktiengesellschaft
 patents
silverMedal4 out of 32 
 
Troponwerke Gmbh & Co Kg
 patents
bronzeMedal1 out of 8 
 
Troponwerke Gmbh & Co.
 patents

Years Active: 1989-2000

Loading Chart...
Areas of Expertise:
Triazaspirodecanone
Methylchromans
Azaheterocyclylmethyl
Psychosis Treatment
Depression Treatment
Piperidylmethyl
2-Aminomethyl-Chromans
Pyrimidinyl-Piperazine
Anxiety Treatment
Chromans Derivatives
15 patents (USPTO):Explore Patents
1. 6060482 - Triazaspirodecanone-methylchromans (2000-05-09),
2. 5962513 - 2-aminomethyl-chromans effective in the treatment of psychoses and (1999-10-05),
3. 5696137 - Azaheterocyclymethyl-chromans (1997-12-09),
4. 5696136 - Method of treating psychosis using azaheterocyclylmethyl (1997-12-09),
5. 5693653 - Method of treating depression using azaheterocyclylmethyl-chromans (1997-12-02),
6. 5545643 - Azaheterocyclylmethyl-chromans (1996-08-13),
7. 5468882 - 2-aminomethyl-chromans (1995-11-21),
8. 5371094 - Azaheterocyclylmethyl-chromans for treating axiety (1994-12-06),
9. 5326771 - Piperidylmethyl-substituted chroman derivatives (1994-07-05),
10. 5318988 - 2-aminomethyl-chromans (1994-06-07),
11. 5314884 - 2-pyrimidinyl-1-piperazine derivatives processes for their preparation (1994-05-24),
12. 5187276 - 2-pyrimidinyl-1-piperazine derivatives (1993-02-16),
13. 4988809 - 2-pyrimidinyl-1-piperazine derivatives, processes for their preparation (1991-01-29),
14. 4937343 - 2-pyrimidinyl-1-piperazine derivatives (1990-06-26),
15. 4818756 - 2-pyrimidinyl-1-piperazine derivatives, processes for their preparation (1989-04-04),

Title: Wolfgang Dompert: Innovator in Medicinal Chemistry

Introduction

Wolfgang Dompert is a distinguished inventor based in Cologne, Germany, known for his significant contributions to medicinal chemistry. With a total of 15 patents to his name, he has made remarkable advancements in the field, particularly in the development of compounds aimed at treating central nervous system disorders.

Latest Patents

Among his latest innovations are the Triazaspirodecanone-methylchromans. These compounds are synthesized by reacting methylchromans, which are substituted on the methyl group by appropriate leaving groups, with triazaspirodecanones. The resulting substances are valuable for the production of medicaments, especially those targeting disorders of the central nervous system. Another notable patent involves 2-aminomethyl-chromans, which are effective in treating psychoses and diseases characterized by disturbances of the serotoninergic system, including psychoses and depression.

Career Highlights

Throughout his career, Wolfgang Dompert has worked with prominent companies such as Bayer Aktiengesellschaft and Troponwerke GmbH & Co. KG. His work in these organizations has allowed him to develop and refine his innovative ideas, contributing to the advancement of medicinal chemistry.

Collaborations

Wolfgang has collaborated with notable colleagues, including Thomas Glaser and Hans-Georg Heine, further enhancing his research and development efforts in the field.

Conclusion

Wolfgang Dompert's contributions to medicinal chemistry through his patents and collaborations have significantly impacted the treatment of various central nervous system disorders. His innovative spirit continues to drive advancements in the field, making him a notable figure in the world of inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…